Neumora Therapeutics is trading 5.31% down at $0.39 on October 22, 2026, amid weakness across the broader market. - The S&P 500 was down 1.03% and the Nasdaq Composite was down 2.04%. - Reporting also described pressure from rising oil prices and geopolitical tensions. No fresh company-specific announcement explaining the move was found; earlier clinical setbacks are prior context, not a confirmed catalyst for this session.